Cannabinoid Clinical Trials: Cannabis in HIV Smoking Care
Cannabinoid clinical trials hiv smoking cessation show promising feasibility and acceptability for people living with HIV. Digital therapeutics tailored to this population offer scalable smoking cessation solutions. These trials highlight the potential…
What This Lancet Review Really Says About Cannabinoids in Psychiatry
A new Lancet Psychiatry review examined 54 randomized trials of cannabinoids for mental disorders and substance use disorders, and the evidence was thinner than many public claims suggest. A few outcomes showed signals, especially in cannabis use…
Pres. Trump’s Marijuana Executive Mandate Accelerates MMJ International Holdings … – Newswire
Pharmaceutical-grade cannabis international markets are evolving due to federal policy changes. GMP-certified producers are positioned to scale and export medical cannabis products. This shift may improve product consistency and availability for patients.
AEF0117 THC Interaction Trial Withdrawn: Implications for Selective CB1 Modulation
The withdrawal of the AEF0117 trial delays progress in selective CB1 receptor modulation for managing THC-related effects. This setback impacts potential pharmacological treatments for cannabis use disorder. Clinicians and patients face longer timelines…
Urgent Need for Clinical Trials on Cannabinoids in HR+ Breast Cancer Therapy
Cannabinoids hormone receptor-positive breast cancer therapy is an emerging area of research. Current evidence suggests cannabinoids may interact with endocrine treatments. Clinical trials are urgently needed to clarify these effects.